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Pemphigus is a group of human autoimmune blistering diseases of the skin in which autoantibodies to desmosome cadherins
induce loss of cell-cell adhesion (acantholysis). In addition to steric hindrance and activation of intracellular signaling, apoptosis
has been suggested to contribute to the mechanism by which pathogenic IgG induces acantholysis. We review the current literature
examining the role of apoptosis in pemphigus. Current data suggest that apoptosis is not required for blister induction, but
that activation of proapoptotic proteins, including caspase cysteine proteinases, may sensitize cells to the acantholytic eﬀects of
pemphigus IgG.
1.Introduction
Pemphigus is a group of autoimmune blistering diseases
characterized by loss of keratinocyte cell adhesion that leads
to clinical blister formation. Pemphigus vulgaris (PV) and
pemphigus foliaceus (PF) are the two main variants. In
these disorders, autoantibodies to desmosome cadherins
induce blister formation. In PF, pathogenic IgG target the
desmosome cadherin desmoglein-1 (dsg-1) [1], inducing
loss of adhesion in the subcorneal region of epidermal
epithelia; whereas, in PV, antibodies to desmoglein-3 (dsg-3)
in mucosal PV [2] and to dsg-3 and dsg-1 in mucocutaneous
PV [3–5] induce loss of adhesion in the suprabasal layer.
2. SignalTransductionandAcantholysis
When injected into neonatal mice, IgG fractions from
pemphigus patients induce blister formation reproducing
the histology, immunohistology, and clinical appearance of
the human disease [6, 7]. This seminal observation pro-
vided the evidence that the autoantibodies themselves were
pathogenic, inducing blister formation in the target organ,
the skin. A variety of mechanisms have been proposed to
explain how pemphigus autoantibodies disrupt keratinocyte
cell-cell adhesion. The observation that pemphigus IgG
were directed against the desmosomal cadherins dsg-1 and
dsg-3 led to the suggestion that the IgG inhibited trans
interactions of desmosome adhesion proteins across the
adhesiveinterface,amechanismknowasthesterichindrance
hypothesis. Alternative hypotheses have been suggested,
including antibody induction of intracellular signaling that
leads to loss of adhesion, and antibody induction of ker-
atinocyte apoptosis.
Changes in cell-cell adhesion are often accompanied by
signiﬁcant alterations in the biology of the cell. When cells
becomeadherenttoadjacentcells,theyoftenceasetomigrate
and proliferate, a concept referred to as contact inhibition
and loss of which often characterizes the malignant pheno-
type of cancer cells. In contrast, when cells lose adhesion to
their neighbors, they can undergo apoptosis, or proliferate,
and, or migrate. Which of these later fates occur is often
context dependent. For example, loss of adhesion to and
migration from the wound margin is typical of the biology
of a keratinocyte migrating into a healing wound. Therefore,
itisnotsurprising thatalterationsincelladhesioncomplexes
initiate, inhibit, and/or regulate signaling processes.
Kitajima’s group was the ﬁrst to describe the activation
of signaling pathways in cells exposed to pemphigus IgG.2 Dermatology Research and Practice
They ﬁrst reported increased intracellular calcium levels
in keratinocytes treated with sera from PV patients [8].
In subsequent studies, using either PV sera or fractions
enriched for pathogenic IgG, they demonstrated activation
of additional signaling molecules including protein kinase C
[9] and phospholipase C [10]. Other signaling events have
been observed in pemphigus treated keratinocytes and may
contribute to loss of or to biologic transitions induced by
altered adhesion [11–18].
3.Apoptosis
Programmed cell death is a mechanism used by multicellular
organisms to remove unwanted cells. For example, the
shaping of tissues during development is a coordinated
process of proliferation, migration, and cell death. In fully
developed organisms, tissues that continuously proliferate,
including the skin, must balance cell proliferation and death
to prevent unchecked growth. In pathologic states, including
actinic damage that may lead to neoplastic transformation,
apoptosis is employed to remove from the host tissue these
potentially damaging cells. Apoptosis is characterized by
a number of well recognized cytological and biochemical
features including, (i) nuclear condensation, (ii) activation
of caspase cysteine proteinases, (iii) DNA fragmentation
at regular intervals resulting in DNA laddering, (iv) cell
shrinkage, and (v) membrane blebbing (reviewed in [19]).
A number of reports indicate that apoptosis occurs
as a consequence of exposure of human keratinocytes to
pemphigusseraorpuriﬁedIgGfractions,observedinbothin
vitro tissue culture systems, in vivo utilizing passive transfer
mouse models, or in human patient skin biopsies. Induction
of apoptosis or of proapoptotic proteins by pemphigus
IgG may be (i) part of the mechanism by which sera
and IgG induce acantholysis or (ii) a consequence of loss
of adhesion and a result of acantholysis. Apoptosis has
been proposed to have a role in the mechanism by which
pemphigus IgG induce acantholysis [20, 21]. Initial reports
examined histological sections of skin biopsies and TUNEL
positive keratinocytes, indicative of DNA fragmentation
characteristic of cells undergoing apoptosis, in both lesional
PF [22]a n dP V[ 20] and in perilesional pemphigus skin
[23]. Markers for apoptotic cells, apart from TUNEL include
components of the proapoptotic pathway such as caspases,
PARP, or Fas. These proapoptotic markers have also been
used to investigate the presence of apoptotic cells in PV
patient skin biopsies.
4.ImmuneCellsandFas/FasL
Although there is a fairly broad consensus that apoptosis
can be observed in pemphigus IgG induced disease pro-
cesses, there remains an ongoing discussion about whether
apoptosis is a (i) cause, (ii) result, or (iii) “byproduct” of
acantholysis. For example, modeling anoikis, it would be
straightforward to think of apoptosis as consequence of
acantholysis. Anoikis is a special form of apoptosis of
epithelial cells triggered when cells become detached from
the substratum. Disruption of integrin-extracellular matrix
binding is a main trigger for anoikis [24]. In contrast, the
main adhesive forces between cells in the suprabasal layers
of the epidermis are adherens junctions and desmosomes;
therefore, anoikis seems to be unlikely to be important in
pemphigus. Furthermore, it has been reported that PV IgG,
but not normal human IgG, cause cell death as measured by
trypan blue exclusion in suspension keratinocytes [25]. The
ability of pemphigus IgG to induce cell death in nonadherent
keratinocytes would seemingly exclude the loss of cell attach-
ment as a trigger for pemphigus IgG induced cell death.
As early as 1994, Sayama and coworkers, and later
other groups, reported upregulation of soluble Fas ligand
in either PV patient sera and, or skin, suggesting that
apoptosisinthetargetorganskinistriggeredviatheFas/FasL
system [20, 23, 26, 27]. Importantly, anti-FasL blocking
antibodies only partially inhibited this proapoptotic eﬀect
of pemphigus sera on cultured keratinocytes suggesting
that other mechanisms may contribute to induction of
apoptosis. Rodrigues and colleagues also reported observing
TUNEL positive keratinocytes in perilesional biopsies in
patients with Fogo selvagem, the endemic form of PF [28].
Interestingly, these authors also noted the presence of the
inﬂammatory cytokines TNF-α,I F N - γ, and IL-1 in the
lesion exudate which led them to suggest that inﬂammatory
mediators could contribute to the induction of apoptosis
in pemphigus. Similarly, Pacheco-Tovar and colleagues sug-
gested that CD8+FasL+ lymphocytes in pemphigus skin may
have a role in inducing apoptosis [26]. In contrast, other
groups have suggested that pemphigus associated apoptosis
is independent of changes in Fas-ligand levels. For example,
Reich and colleagues did not see increased levels of FasL in
PNP patient sera, despite observing increased apoptotic cells
in PNP skin biopsies [29].
Genetic polymorphisms in genes encoding apoptotic
factors have been identiﬁed in autoimmune disorders.
K¨ ohler and Petzl-Erler reasoned that if apoptosis has a role
in pemphigus, then genetic polymorphisms in apoptotic
factors might similarly explain the susceptibility of certain
individuals to this disease; however, they were unable to
ﬁnd an association between speciﬁc polymorphisms in the
genes encoding either the p53 or BAX in a Brazilian focus of
endemic PF [30].
Taken together, pemphigus lesions have been described
with or without the inﬁltration of immune cells suggesting
that inﬂammation is not necessarily an early event nor
required for pemphigus disease induction. Nevertheless, the
latter observation could explain the contradictory ﬁnding
of the presence or absence of FasL in pemphigus lesions by
diﬀerent labs.
5. The Temporal Association of
AcantholysisandApoptosis
Apoptosis leads to cell death; whereas, in pemphigus, the
engagement of cell surface antigens by pathogenic leads to
loss of adhesion, a point discussed by Grando and colleagues
in a recent commentary [31]. The timing of these events and
their relation to one another, that is the loss of adhesion
and activation of proapoptotic proteins, has been subject toDermatology Research and Practice 3
debate and investigation. Grando uses the term apoptolysis
to suggest a relationship between the activation of apoptotic
proteins including caspases, and acantholysis emphasizing
that caspase activation and acantholysis can proceed in the
absence of cell death. Namely, that caspases could serve cell
regulatory functions in addition to apoptosis. In support of
this hypothesis is data demonstrating that many desmosome
components as well as intermediate ﬁlaments can serve as
caspase substrates [32–35]. Thus, caspases may have a role
in regulating desmosome protein turnover under normal as
well as pathophysiologic states.
Diﬀering reports on the role of apoptosis in pemphi-
gus IgG mediated acantholysis may reﬂect the diﬀerent
systems and experimental conditions used. For example,
diﬀerent keratinocyte culture systems, including primary
human keratinocytes, squamous cell carcinoma cell lines,
and the immortalized HaCat keratinocyte cell line, have
been used to examine in vitro the role of apoptosis in
pemphigus acantholysis. Similarly, cell cultures that have
been passaged multiple times, believed to reproduce some of
the biochemical and physiologic alterations associated with
aging, appear more susceptible to the apoptosis inducing
activityofpemphigusIgG[36].Utilizingcellculturesystems,
extended incubations are often used to examine the ability
of pemphigus sera or pemphigus IgG to induce keratinocyte
apoptosis. Incubations with pemphigus sera and/or IgG
from 8 to 72 hours have been used in experiments in
which activation of proapoptotic markers including TUNEL
positivity have been observed at typically later time points
[37]. Moreover, monolayer cultures cannot fully replicate
the in vivo situation, as cells in culture are proliferating;
whereas, the cells aﬀected and involved in pemphigus disease
processes are suprabasal keratinocytes that have ceased to
proliferate, but are diﬀerentiating. Diﬀerences in prolifera-
tion and diﬀerentiation could lead to altered susceptibility to
apoptotic stimuli. Skin biopsies are a snapshot in time of the
disease progression and reported diﬀerences in the biopsies
may be attributed to diﬀerent stages of disease progression.
Whileveryearlydiseaselesionsmaybenegativeforapoptotic
markers, late lesions may show apoptosis as well as immune
cell inﬁltrates.
6.The InVivoEffect ofCaspaseInhibitors
Li and colleagues explored the ability of caspase inhibitors
to block acantholysis in vivo using the PF passive transfer
mouse model [38]. They reported that pretreatment of
neonatal mice with 0.034–6.8μg/g body weight of the
caspase inhibitors Ac-DEVD-cmk or Boc-D-fmk prevented
PF IgG induced blister formation in the mice at 20 hours.
Interestingly, in time course studies they observed increased
amounts of the proapoptotic factor Bax initially and sub-
sequent decreases in the antiapoptotic factor Bcl-xL at later
time points, an observation they suggest supports a role for
induction of apoptosis via the mitochondrial pathway. They
interpret these results to implicate caspase activity in the
mechanism of acantholysis. This report stands in contrast to
an in vitro study by Schmidt and colleagues suggesting that
caspase inhibitors do not block acantholysis [39]. Using the
immortalized HaCat keratinocyte cell line as well as normal
human epidermal keratinocyte cultures as in vitro model
systems, they observed PV IgG induced keratinocyte dissoci-
ation and cytokeratin retraction without observable markers
of apoptosis such as nuclear condensation, TUNEL staining,
and caspase-3 activation. The caspase inhibitor z-VAD-fmk
did not block PV IgG mediated acantholysis in cultured
keratinocytes. In addition to using pharmacologic inhibitors
of apoptosis, genetic approaches also failed to demonstrate
a role for apoptosis in PV IgG mediated acantholysis. In
these experiments, overexpression in HaCat cells of the
Fas-associateddeathdomain-likeinterleukin-1-β-converting
(FLICE)-like inhibitory proteins FLIPL and FLIPS, inhibitors
of caspase-8 mediated activation and apoptosis, blocked Fas
induced apoptosis, but failed to block PV IgG mediated
acantholysis. An additional important ﬁnding in the above
mentioned report is that not all lesions from the same
patients, particularly very early ones, showed markers of
apoptosis, an observation suggesting that apoptosis is not
essential for acantholysis.
7. Pemphigus, P38MAPK, Acantholysis,
andApoptosis
In a series of experiments initially designed to look at
signaling pathways downstream of changes in desmosome
mediated cell-cell adhesion, our research group identiﬁed
activation of p38 mitogen activated protein kinase (MAPK)
as a necessary event for pemphigus IgG induced acantholysis
[40]. Phosphorylation is a common, reversible modiﬁcation
that regulates protein structure, function, and activity.
Because changes in protein phosphorylation are common
in signal transduction cascades and can be readily detected
and quantiﬁed with radioactive phosphate, we designed a
strategy to screen for signaling downstream of pemphigus
IgG induced changes in desmosome mediated adhesion.
Primary human keratinocytes were loaded with 32P-H3PO4
and then exposed to puriﬁed PV IgG for 30 minutes. Protein
extracts were prepared from labeled cells and separated by
two-dimensional gel electrophoresis. Radioactive proteins
were detected by autoradiography and quantiﬁed by phos-
phoimage analysis. Using this approach, we identiﬁed several
radioactive spots whose signal was consistently increased in
samples treated with PV IgG, but not in normal human
IgG nor buﬀer treated controls. Through this screen we
ﬁrst identiﬁed the small heat shock protein (HSP) 27 and
p38MAPK as components of a putative signaling cascade
downstream of PV IgG induced changes in desmosome
adhesion. Because p38MAPK was known to be upstream of
HSP27, it was not surprising that keratinocytes pretreated
with the p38MAPK inhibitors SB202190 or SB203580, but
not the inactive analog SB202474, failed to induce HSP27
phosphorylation when treated with PV IgG. What was
surprising was that the p38MAPK inhibitors also blocked PV
IgG induced actin reorganization and keratin intermediate
ﬁlament retraction. This observation suggested that activa-
tion of p38MAPK might not be a signal activated by loss
of adhesion, but could in fact be part of the mechanism by
which PV IgG induced loss of adhesion. These observations4 Dermatology Research and Practice
were later conﬁrmed using passive transfer mouse models
of both PV [41]a n dP F[ 42]. Phosphorylation of both
HSP27 and p38MAPK were observed in skin biopsies from
PV and PF IgG treated neonatal mice. Signiﬁcantly, in
mice pretreated with p38MAPK inhibitors, p38MAPK and
HSP27 phosphorylation and blister formation were blocked.
Activation of p38MAPK in keratinocytes treated with PV
IgG has now been independently conﬁrmed by several labs
actively investigating the mechanism of acantholysis [12, 16,
43].
Our earlier studies had demonstrated a role for
p38MAPK in the mechanism by which pemphigus IgG
induce acantholysis. Based on (i) the known roles of
p38MAPK and HSP27 in regulating both the actin and
intermediate ﬁlament cytoskeletons [44–50] and (ii) the
abilityofp38MAPKinhibitorstoblockPVIgGinducedactin
reorganization and keratin intermediate ﬁlament collapse
in keratinocyte tissue cultures [40], we had proposed that
p38MAPK was acting upstream of and regulating both
actin and keratin intermediate ﬁlament cytoskeletal changes
induced by pemphigus IgG. Recent work in our lab has also
demonstrated a role for p38MAPK in regulating pemphigus
IgG induced desmoglein endocytosis [51].
Because of the well-characterized involvement of
p38MAPK in apoptosis [52–54], we initiated a series of
experiments to investigate the potential relationship of PV
IgG induced activation of p38MAPK to apoptosis [55]. In
this series of experiments, both tissue culture and animal
model systems were employed. Primary human keratinocyte
cultures allowed us to very accurately follow the time course
of biochemical changes induced by pemphigus IgG; whereas,
utilization of the pemphigus passive transfer mouse model
allowed us to determine if the events observed in vitro were
reﬂective of the in vivo state. Primary human keratinocytes
were exposed to PV IgG and examined biochemically and
by confocal immunoﬂuorescent microscopy at various times
after addition of PV IgG to the cultures. Interestingly, two
sequential peaks of p38MAPK activation were observed, the
ﬁrst beginning within minutes after addition of PV IgG,
peaking at 30 minutes, and then dropping down to baseline
by 4 hours. A second extended peak of p38MAPK activation
w a so b s e r v e dt ob e g i na t6h o u r sa n dc o n t i n u e do u tt o1 0
hours. Analogous to the observations in tissue culture, a
similar biphasic activation of p38MAPK in the skin was
observed in the passive transfer PF mouse model. An initial
peak of p38MAPK activation was seen at 2 to 4 hours after
subcutaneous administration of puriﬁed PF IgG to neonatal
C57BL/6J mice which dropped down to baseline levels at 6
hours. A second peak of p38MAPK was observed in murine
skin at 8 hours post PF IgG injection and was sustained out
to at least 21 hours post injection. Along with p38MAPK
activity, markers of apoptosis, including TUNEL staining,
PARP cleavage, and caspase-3 cleavage were also examined
at sequential time points after treatment with pemphigus
IgG. In both primary human keratinocyte cultures and the
passive transfer mouse model, markers of apoptosis were
late events occurring coincident or subsequent to the second
peak of p38MAPK activation. In the passive transfer mouse
model, acantholysis was readily apparent at 21 hours after
treatment with PF IgG; however, neither cleaved PARP nor
cleaved caspase-3 could be detected at either the 21- or 24-
hour-time points, well after the second peak of p38MAPK
activity had begun. It was not until 30 hours post PF IgG
injection that these markers of apoptosis (cleaved PARP and
cleaved caspase-3) were detected by immunoblot of skin
extracts. Similarly, only in skin biopsies from mice treated
with PF IgG for times exceeding 21 hours were increases in
TUNEL positive keratinocytes detected.
To investigate the relationship of the ﬁrst and second
peak of p38MAPK activity to acantholysis, and apopto-
sis, inhibitor experiments were performed in both pri-
mary human keratinocyte culture and passive transfer
mouse models. By either pretreating cultures or mice
with p38MAPK inhibitors prior to pemphigus IgG or at
a time after the ﬁrst, but prior to the second peak of
p38MAPK activity, either both peaks or the second peak of
p38MAPK activity could be selectively inhibited. Utilizing
this approach, inhibition of the ﬁrst, but not second, peak
of p38MAPK activity inhibited blister formation in vivo and
c y t o k e r a t i nr e t r a c t i o ni nv i t r o[ 55]. We interpreted these
results to indicate that the ﬁrst, but not second peak, of
p38MAPK activity observed after exposure to pemphigus
IgG was part of the mechanism of acantholysis. Importantly,
although it failed to inhibit cytokeratin retraction and
acantholysis, selective inhibition of the later second peak
of p38MAPK activity inhibited caspase-3 activation in vivo.
Thus, the time course studies revealed that apoptosis occurs
at or after the second peak of p38MAPK activation and that
inhibition of this later peak of p38MAPK activity blocked
activation of the proapoptotic proteinase caspase-3, but not
acantholysis. Collectively, these observations suggest that the
earlierpeakofp38MAPKactivationispartofthemechanism
leading to acantholysis; whereas, the later peak of p38MAPK
and apoptosis are subsequent to and likely not essential for
acantholysis (Figure 1).
Interestingly, pemphigus IgG induced cytokeratin retrac-
tion may trigger apoptosis as suggested by a recent report
from the Omary lab implicating a role for keratin inter-
mediate ﬁlaments in the induction of apoptotic pathways.
Mutations in the hepatocyte keratin K8 were associated with
altered mitochondrial morphology and increased suscepti-
bility to proapoptotic stimuli [56]. Null K8 or K8 mutants
show decreased mitochondrial size, a shift from diﬀuse to
cortical distribution and clumping, and increased mitochon-
drial release of cytochrome c from mutants. Therefore, it
may be the collapse of the intermediate ﬁlament network
in pemphigus that contributes to activation of apoptosis in
these cells.
8.MakingSenseofItAll
From studies to date, it is clear that activation of proapop-
totic proteins, including caspases, occurs in pemphigus.
Although studies from our lab and from Waschke’s group
indicate that apoptosis is not essential for acantholysis
to proceed, Li and coworkers have shown that caspase
inhibitors can block acantholysis in the PF passive transfer
mouse model. The challenge of resolving these seeminglyDermatology Research and Practice 5
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Figure 1:Pemphigus,p38MAPK,acantholysisandapoptosis.Twosequentialpeaksofp38MAPKactivationareobservedwhenkeratinocytes
are exposed to either PV or PF IgG. (a) Pemphigus IgG binds to dsg and biases the equilibrium of desmosome assembly/disassembly towards
disassembly which is linked by an, as yet, undeﬁned mechanism towards activation of p38MAPK. Subsequent p38 dependent alterations in
the cell state include RhoA inactivation, dsg endocytosis, HSP27 phosphorylation, keratin intermediate ﬁlament retraction, actin, and loss
of cell-cell adhesion (acantholysis). (b) A second late peak of p38 activity is observed that is likely a stress response signal induced by loss of
cell-cell adhesion and leads to activation of proapoptotic pathways including caspase-3 activation.
mechanistically divergent observations is not as diﬃcult as
it would ﬁrst appear.
Although caspases are cysteine proteinases implicated
in apoptosis, they may have additional nonapoptotic bio-
logic functions [57] including regulating desmosome asse-
mbly/disassembly. This is particularly relevant because data
is accumulating that desmosomes are dynamic complexes
in which the adhesive structure is maintained by the
equilibrium between desmosome assembly and disassembly.
In pemphigus, pathogenic antidsg antibodies promote dsg
internalization [14, 15, 51, 58–61] and bias the equilibrium
towards disassembly. Similarly, caspases have been shown to
cleave desmosome proteins and therefore may be important
to the physiologic cycling/turnover of dsg in keratinocytes.
The desmosome proteins dsg-3, dsg-1, plakoglobin, and
desmoplakin [32, 33], as well as intermediate ﬁlaments
[34, 35], have all been shown to undergo caspase-depen-
dent cleavage. Furthermore, caspases may also regulate
matrix metalloproteinase (MMP) dependent cleavage of
desmogleins[33].InA431epithelialcellsinducedtoundergo
apoptosis by UV exposure, UV-induced MMP cleavage of
dsg-1 ectodomain could be inhibited by both MMP speciﬁc
inhibitors as well as by the caspase inhibitor ZVAD-fmk [33].
Staphylococcal Scalded Skin Syndrome (SSSS) demonstrates
that proteolytic cleavage of desmogleins can cause
acantholysis. In SSSS, the Staphylococci secrete exfoliative
toxin, a serine proteinase that cleaves the ectodomain of
dsg-1; thereby, disrupting desmosome mediated adhesion
in the subcorneal layers of epidermal epithelia and yielding
a phenotype mimicking the subcorneal blisters of PF
[62, 63]. Thus, caspase-dependent proteolysis has the
potential to augment the acantholytic eﬀects of pemphigus
IgG. Analogously, blocking caspase dependent proteolysis
of desmosome proteins and intermediate ﬁlaments may
stabilize keratinocyte cell-cell adhesion thereby increasing
their resistance to pemphigus IgG induced acantholysis.
Pemphigus induced acantholysis is a disease speciﬁc
model system that has facilitated the investigation of desmo-
some dynamics, adhesion, and the mechanisms by which
alterations in desmosome structure impact intracellular
signaling and regulatory pathways. Although activation of
proapoptotic pathways appears to be a late event and may
not be essential for blistering in pemphigus, activation
of components of apoptotic signaling, including caspase
family member proteinases, could augment the blistering
response as downstream eﬀects of p38MAPK activation.
Adhesion is a dynamic process that is linked to other biologic
eventsincludingcellmigration,proliferation,diﬀerentiation,
and death. Changes in desmosome adhesion impact these
processes and is likely to involve multiple components
and signaling pathways. Elucidating these components and
pathwayswillprovidefertilegroundforfutureinvestigations.
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